FibroBiologics, Inc. (FBLG)
NASDAQ: FBLG · Real-Time Price · USD
1.400
-0.020 (-1.41%)
At close: Apr 8, 2026, 4:00 PM EDT
1.370
-0.030 (-2.14%)
After-hours: Apr 8, 2026, 7:56 PM EDT
FibroBiologics Market Cap
FibroBiologics has a market cap or net worth of $6.36 million as of April 8, 2026. Its market cap has decreased by -84.58% in one year.
Market Cap
6.36M
Enterprise Value
3.87M
1-Year Change
-84.58%
Ranking
Category
Stock Price
$1.40
Market Cap Chart
Since January 31, 2024, FibroBiologics's market cap has decreased from $945.52M to $6.36M, a decrease of -99.33%. That is a compound annual growth rate of -89.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 6.45M | -56.89% |
| Dec 31, 2025 | 14.96M | -78.68% |
| Dec 31, 2024 | 70.17M | -92.58% |
| Jan 31, 2024 | 945.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 6.41M |
| BioRestorative Therapies | 6.40M |
| CollPlant Biotechnologies | 6.36M |
| Immuron | 6.27M |
| Addex Therapeutics | 6.25M |
| MetaVia | 6.21M |
| Ernexa Therapeutics | 6.11M |
| XTL Biopharmaceuticals | 6.04M |